GLUCURONIDATED ACETAMINOPHEN AS A MARKER OF HEPATIC DISORDERS

摘要

THE PRESENT INVENTION PROVIDES METHODS FOR DIAGNOSING HUMAN HEPATIC DISORDERS, IDENTIFYING A HUMAN SUBJECT AT RISK OF AN ADVERSE DRUG REACTION, AND DETERMINING AN APPROPRIATE DOSAGE OF A THERAPEUTIC DRUG FOR A HUMAN SUBJECT. (FIGURE 1)